Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collection of Blood to Evaluate Epigenomics and Protein Biomarkers for the Detection of Hepatocellular Carcinoma

NCT05199259 is registered in ClinicalTrials.gov with Helio Genomics as lead sponsor.

NCT NCT05199259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05199259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collection of Blood to Evaluate Epigenomics and Protein Biomarkers for the Detection of Hepatocellular Carcinoma
Lead sponsor
Helio Genomics
Phase
Observational
Overall status
Recruiting
Start date
March 1, 2022
Completion date
December 31, 2028
Enrollment
1,200 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hcc, hepatocellular carcinoma, liver cancer, liver cirrhosis